Enabling Direct Therapeutic Access Beyond the Blood-Brain Barrier BALTIMORE, /PRNewswire/ -- CraniUS Therapeutics LLC, a privately held neurotechnology company, today announced it has raised $20 ...

Modern cancer therapies have resulted in higher survival rates for victims of this dread disease, in many cases. However, their generic mode of delivery and action is associated with greater adverse ...

A hidden communication network between brain cells and glioblastoma tumors may be key to slowing this aggressive cancer.

An interdisciplinary multi-center research team led by the LKS Faculty of Medicine (HKUMed) and Faculty of Dentistry at the ...

A team of Canadian scientists has uncovered a new way to slow the growth of glioblastoma, the most aggressive and currently ...

The Preston Robert Tisch Brain Tumor Center grants first IRB approval for APTN-101’s Phase I clinical trial, enabling patient ...

The human brain comprises billions of neurons, synapses, and cell types, making it one of the universe’s most intricate and dynamic structures. However, the complexity and sensitivity of the brain can ...

Researchers have demonstrated that microscopic drug delivery containers can be magnetically steered to their targets, advancing the development of precision medicine for treating diseases such as ...

A man with the deadliest form of brain cancer has no signs of the disease after taking an experimental drug. Ben Trotman was 40 when he was diagnosed in 2022 with glioblastoma, the most aggressive ...

Scientists at McMaster University and The Hospital for Sick Children (SickKids) have identified a previously hidden population of brain cells that actively fuel glioblastoma growth — and, crucially, ...